MORE►
Perceptive Advisors
David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Courtesy: Caris]
Irving’s Caris Life Sciences Files for IPO, Backed by AI-Driven Precision Oncology Platform
by Lance Murray | May 28, 2025
With $1.86 billion raised since 2018 and recent product launches, the North Texas life science company founded in 2008 is preparing for a public debut on the Nasdaq Global Select Market, following a $168 million growth capital round in April.
by Lance Murray |
Apr 8, 2025
With the new funding, Caris said it has raised $1.86 billion in capital since 2018. Caris will use the raise to bring its science and technologies "to as many patients as possible and further our goal of revolutionizing precision medicine," Founder and CEO David Halbert said.
MORE►
